Krebs Biochemicals And Industries Ltd (KREBSBIO) Share Price Target 2026, 2027 upto 2030

Krebs Biochemicals & Industries Limited (KREBSBIO) belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry. The stock closed at Rs. 52.52 on 23 July 2026. In this updated report, we will explore KREBSBIO share price target for 2026, 2027, 2028, 2029 and 2030 using monthly target data, year-end target ranges, and current technical trends.

For long-term KREBSBIO share price forecast up to 2030, we use multiple ML-based models instead of a single fixed projection. The forecast combines LightGBM quantile regression and ExtraTrees quantile forest to produce bear, base and bull ranges. KREBSBIO's recent data shows a -19.52% one-month move, a -13.76% three-month move, and a -36.33% drawdown from its 12-month high area. Because recent volatility is high and model confidence is medium, these targets are best read as a forecast range rather than a single fixed price.

KREBSBIO Share Price Target 2026 to 2030: Quick View

Based on the latest forecast model, KREBSBIO's 2030 consensus base target is Rs. 134.70. The bear case stands near Rs. 70.73, while the bull case extends up to Rs. 223.10. For 2026, the year-end consensus base target is Rs. 77.92, with a forecast range of Rs. 63.94 to Rs. 98.02.

KREBSBIO Current Performance and 52-Week Position

KREBSBIO Price Recovery Tracker

Recent Closing Prices of KREBSBIO

KREBSBIO Share Price Target 2026

KREBSBIO share price target for 2026 is shown below with bear, base and bull scenarios for each month.

Summary of KREBSBIO Share Price Forecast for 2026

• The initial price target for Krebs Biochemicals & Industries Limited in 2026 is projected near Rs. 64.08, with the forecast range starting from the first available model month. This starts the forecast above the latest close, so the model assumes early follow-through.
• The mid-year price target for Krebs Biochemicals & Industries Limited could reach Rs. 73.27 in the base case. The first-half move is stronger than the full-year average path, so this year is front-loaded in the forecast.
• By the end of 2026, the price target for Krebs Biochemicals & Industries Limited is projected near Rs. 77.92 in the base case, while the bear-to-bull range stands between Rs. 63.94 and Rs. 98.02. The base path remains clearly positive, and the range is not unusually wide for this year.

KREBSBIO Share Price Target 2027

KREBSBIO share price target for 2027 is shown below with bear, base and bull scenarios for each month.

Summary of KREBSBIO Share Price Forecast for 2027

• The initial price target for Krebs Biochemicals & Industries Limited in 2027 is projected near Rs. 86.85, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Krebs Biochemicals & Industries Limited could reach Rs. 103.19 in the base case. The first-half move is stronger than the full-year average path, so this year is front-loaded in the forecast.
• By the end of 2027, the price target for Krebs Biochemicals & Industries Limited is projected near Rs. 81.98 in the base case, while the bear-to-bull range stands between Rs. 66.02 and Rs. 97.00. This makes the year cautious in the base case, with the bear scenario carrying more weight than usual.

KREBSBIO Share Price Target 2028

KREBSBIO share price target for 2028 is shown below with bear, base and bull scenarios for each month.

Summary of KREBSBIO Share Price Forecast for 2028

• The initial price target for Krebs Biochemicals & Industries Limited in 2028 is projected near Rs. 83.12, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Krebs Biochemicals & Industries Limited could reach Rs. 89.06 in the base case. The first-half movement is steady, with no sharp jump between the opening and mid-year targets.
• By the end of 2028, the price target for Krebs Biochemicals & Industries Limited is projected near Rs. 96.74 in the base case, while the bear-to-bull range stands between Rs. 67.50 and Rs. 128.04. This points to a moderate upward base case rather than an aggressive one-way forecast.

KREBSBIO Share Price Target 2029

KREBSBIO share price target for 2029 is shown below with bear, base and bull scenarios for each month.

Summary of KREBSBIO Share Price Forecast for 2029

• The initial price target for Krebs Biochemicals & Industries Limited in 2029 is projected near Rs. 98.09, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Krebs Biochemicals & Industries Limited could reach Rs. 105.09 in the base case. The range is wide by mid-year, so the base target should be read with the lower and upper scenarios.
• By the end of 2029, the price target for Krebs Biochemicals & Industries Limited is projected near Rs. 114.16 in the base case, while the bear-to-bull range stands between Rs. 69.07 and Rs. 169.01. This points to a moderate upward base case rather than an aggressive one-way forecast.

KREBSBIO Share Price Target 2030

KREBSBIO share price target for 2030 is shown below with bear, base and bull scenarios for each month.

Summary of KREBSBIO Share Price Forecast for 2030

• The initial price target for Krebs Biochemicals & Industries Limited in 2030 is projected near Rs. 115.74, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Krebs Biochemicals & Industries Limited could reach Rs. 124.00 in the base case. The range is wide by mid-year, so the base target should be read with the lower and upper scenarios.
• By the end of 2030, the price target for Krebs Biochemicals & Industries Limited is projected near Rs. 134.70 in the base case, while the bear-to-bull range stands between Rs. 70.73 and Rs. 223.10. For 2030, the full range is more important than the single base number because long-horizon model uncertainty is higher.

KREBSBIO Historical Price and Possible Forecast Path

The chart below combines KREBSBIO's available monthly closing history with possible bear, base and bull forecast paths up to 2030. Once the latest page data is regenerated, the history section can show up to five years of month-end closes. The shaded area marks the forecast period, so the future section should be read as scenario data, not a confirmed price path.

Model Comparison for KREBSBIO Forecast

KREBSBIO Bear, Base and Bull Case Explained

How Strong Is the KREBSBIO Forecast Agreement?

For 2030, the model gap between LightGBM and ExtraTrees is 0.00%, which is classified as tight agreement. A tight gap means both models are reading the long-term setup similarly, while a wide gap means the final target should be read with more caution.

Key Takeaways from Forecasted Price for KREBSBIO from 2026 to 2030

• 2026: The base target moves from Rs. 64.08 to Rs. 77.92, while the year-end range is Rs. 63.94 to Rs. 98.02.
• 2027: The base target moves from Rs. 86.85 to Rs. 81.98, while the year-end range is Rs. 66.02 to Rs. 97.00.
• 2028: The base target moves from Rs. 83.12 to Rs. 96.74, while the year-end range is Rs. 67.50 to Rs. 128.04.
• 2029: The base target moves from Rs. 98.09 to Rs. 114.16, while the year-end range is Rs. 69.07 to Rs. 169.01.
• 2030: The base target moves from Rs. 115.74 to Rs. 134.70, while the year-end range is Rs. 70.73 to Rs. 223.10.

What Is Driving the KREBSBIO Share Price Forecast?

• Momentum: KREBSBIO has moved -19.52% over 1 month and -13.76% over 3 months, which makes the recent trend state weak recent trend.
• Volatility: The volatility reading is 52.51%, so the forecast range is read with high volatility.
• Price position: The stock is in the middle part of its 12-month range, with a -36.33% drawdown from the recent high.
• Model agreement: The model comparison table shows whether LightGBM and ExtraTrees are close or wide for the long-term base target.

What Can Change the KREBSBIO Forecast?

• If KREBSBIO moves back above its 200-day average, the long-term setup can improve because the current SMA 200 status is below its 200-day average.
• If the stock fails to recover from the middle part of its 12-month range, the bear case becomes more relevant than the base case.
• If volatility stays high, the forecast range can remain wide even when the base target moves higher.
• If future model batches reduce the 0.00% 2030 model gap, the long-term target range may become easier to interpret.

Risks and Uncertainty in KREBSBIO Long-Term Target

The main uncertainty in the KREBSBIO share price target comes from the wide 2030 range, high volatility, and tight model agreement. Long-term forecasts can change materially when new price history, trend data or volatility data is added to the model.

FAQs on KREBSBIO Share Price Target

What is KREBSBIO share price target for 2030?

KREBSBIO share price target for 2030 has a consensus base case of Rs. 134.70. The bear case is Rs. 70.73, while the bull case is Rs. 223.10.

What is KREBSBIO share price target for 2026?

KREBSBIO share price target for 2026 has a year-end base target of Rs. 77.92, with a forecast range of Rs. 63.94 to Rs. 98.02.

Is the KREBSBIO forecast based on machine learning?

Yes. The forecast uses LightGBM quantile regression and ExtraTrees quantile forest, then shows a consensus range.

Can KREBSBIO reach Rs. 134.70 by 2030?

The 2030 base case shows Rs. 134.70, which is +156.47% from the latest close. This is a possible model scenario, not a guaranteed target.

What is the bear case target for KREBSBIO in 2030?

The bear case target for KREBSBIO in 2030 is Rs. 70.73, implying +34.67% from the latest close.

What is the bull case target for KREBSBIO in 2030?

The bull case target for KREBSBIO in 2030 is Rs. 223.10, implying +324.79% from the latest close.

Why does the KREBSBIO forecast range matter?

The forecast range matters because the 2030 range is wide and the model agreement is tight. A wider range means the long-term estimate has more uncertainty.

Is this KREBSBIO target a buy or sell recommendation?

No. These targets are scenario-based forecasts generated from price and technical data. They should not be treated as a buy, sell or hold recommendation.